A Targeted Approach to Address Unmet Needs in Oncology and Infectious Diseases
The Hemopurifier is a clinical-stage therapeutic device designed to selectively remove circulating pathogenic targets from biologic fluids.
It is being developed to improve outcomes in patients with cancer and life-threatening viral infections.
Holds U.S. FDA Breakthrough Device designations in oncology and infectious disease.
Breakthrough Device designations include:
- Advanced or metastatic cancer unresponsive or intolerant to standard-of-care therapy
- Life-threatening viral infections not addressed with approved therapies
More About Our Hemopurifier®
